The expression of inhibitory receptors on leukocytes in allergic rhinitis. (EXIRA-study) - EXIRA

niversitair Medisch Centrum Utrecht0 个研究点目标入组 84 人开始时间: 待定最近更新: 2024年5月6日

适应症

试验速览

暂无简介。

•Patients with allergic rhinitis
•-Age 18-35 years
•-No severe co-morbidity, other than allergic symptoms
•-Proven allergic rhinitis (based on clinical evaluation of a medical doctor or with positive RAST) experiencing at least nasal symptoms
•-Suffering from outdoor allergies (hay fever, pollen, weeds, grass) or indoor allergies (mold, dust, dust mite) or pet allergies.
•- Good understanding of the Dutch language
•- Willingness to receive a member of the investigation team in the house of the participant;Controls
•-Healthy individuals 18-35 years with a runny nose

•-Any severe comorbidity
•-Any other infection during the department visit
•-Immunological nasal disease (Churg-Strauss syndrome, Sjögren*s syndrome, systemic lupus erythematosus, sarcoidosis, Wegener*s granulomatosis)
•-Use of nasal corticosteroid spray 1 month or less prior during the hospital visit.
•-Use of oral corticosteroids 1 month or less prior during the hospital visit.

发起方

niversitair Medisch Centrum Utrecht